- Home
- CATX vs AGD Comparison
CATX vs AGD Comparison
Compare CATX & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CATX | AGD |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 341.0M | 329.6M |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CATX | AGD |
|---|---|---|
| Price | $2.99 | $12.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $12.11 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 131.4K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.96 | $10.41 |
| 52 Week High | $6.16 | $13.98 |
Technical Indicators
Market Signals| Indicator | CATX | AGD |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 61.79 |
| Support Level | $2.82 | $12.19 |
| Resistance Level | $4.27 | $12.65 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 62.77 | 96.49 |
Price Performance
Historical ComparisonAbout CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors, among others.